Positron emission tomography (PET) is a molecular diagnostic imaging technology to quantitatively visualize biological processes in vivo. For many applications, including imaging of low-tissue density targets (e.g., neuroreceptors), imaging in small animals, and evaluation of novel tracers, the injected PET tracer must be produced with high molar activity to ensure low occupancy of biological targets and avoid pharmacologic effects. Additionally, high molar activity is essential for tracers with lengthy syntheses or tracers transported to distant imaging sites. Here we show that radiosynthesis of PET tracers in microliter volumes instead of conventional milliliter volumes results in substantially increased molar activity, and we identify the most relevant variables affecting this parameter. Furthermore, using the PET tracer [ 18 F]fallypride, we illustrate that molar activity can have a significant impact on biodistribution. With full automation, microdroplet platforms could provide a means for radiochemists to routinely, conveniently, and safely produce PET tracers with high molar activity.
P ositron emission tomography (PET) is an effective in vivo molecular imaging technology in clinical care, preclinical and clinical research, and drug discovery [1] [2] [3] [4] [5] . PET applications span a broad range of medical fields, including oncology, cardiology, immunology, and neurology. In the latter, for example, PET is used in the diagnosis and monitoring of neurodegenerative disorders 6 , and is a vital tool in the discovery and development of novel therapeutics by enabling in situ measurements of drug target occupancy, binding kinetics, etc. 7 . Based on the principles of "tracer kinetics", PET enables measurements of biological processes such as receptor occupancy, cell proliferation, metabolism, apoptosis, and gene expression, quantification of their temporal changes, and identification of their roles in the mechanisms of disease without perturbing the underlying biology 8, 9 . While PET tracers have been developed incorporating various radionuclides 10 , those labeled with fluorine-18 are of particular interest due to the wide availability of this radionuclide and its favorable physical and chemical properties 11 .
During synthesis of PET tracers, inevitable contamination by sources of non-radioactive [ 19 F]fluoride leads to a final product comprising a mixture of 18 F-and 19 F-labeled molecules, of which only the former are detectable by the PET scanner. Molar activity (A m ; commonly referred to as "specific activity") describes the ratio of the radioactivity (i.e., quantity of 18 F-labeled molecules) to the total quantity of radioactive plus non-radioactive (i.e., 19 Flabeled) molecules [12] [13] [14] . High A m of PET tracers is critical for many applications [15] [16] [17] : it minimizes occupancy when imaging low tissue density targets (e.g., neuroreceptors) 5, 18-21 , facilitates PET "microdosing" studies to evaluate the pharmacokinetics of novel drug compounds [22] [23] [24] [25] , extends the distance/time over which tracers can be transported to the imaging site 26 , and is critical in preclinical research, where much higher concentrations of the tracer per mass of the animal must be injected (compared to humans) to achieve sufficient signal-to-noise ratio 19, 20, 27 .
The theoretical maximum A m of a radiofluorinated tracer is A max m = 1710 Ci/µmol [63.3 TBq/µmol] (i.e., all molecules are labeled with 18 F). However, reported A m values are most typically in the 0.5-1.0 Ci/µmol [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] GBq/µmol] range (for nucleophilic radiofluorination) 26 , though there is considerable variation 28 and a few reports of significantly higher A m . Though there is not a consensus on what constitutes "high" A m , we consider values >5 Ci/µmol [>185 GBq/µmol] to be "high". The discrepancy of three orders of magnitude between typical and maximum theoretical A m can be attributed to [ 19 F] fluoride contamination in the radioisotope solution (i.e., from cyclotron production and delivery process) and/or from the radiosynthesis process itself (i.e., from reagents and/or synthesis apparatus). Since [ 18 F]fluoride and [ 19 F]fluoride have the same reactivity, both are incorporated into the precursor nearly in proportion to their abundance. Thus, the molar activity of a tracer can be expressed as: 31 . However, the use of such large amounts of radioactivity poses safety challenges in production and handling of the tracer, and can lead to significant radiolysis of the product 32 . Furthermore, the costs associated with using higher amounts of radioactivity may be difficult to justify if the goal is only to perform a small number of patient scans or to perform preclinical imaging. As an aside, another approach for increasing molar activity that is not reflected in Eq. 1 is the addition of multiple labeling sites per tracer molecule 16 . Using trifluoroborate derivatives, tripling of molar activity has been reported 33 .
Reducing the amount of 19 F-contamination (i.e., 19 increased) for most cyclotrons, most radiochemists will not have control over this aspect of the tracer production. Contamination from the synthesis process ( 19 F s ) is generally even more significant and thus dominates the molar activity of the final tracer. In one study, radiolysis of Teflon was found to be a major source, with 90-95% reduction of contamination by avoiding Teflon (tubing, stir bars, etc.) 37 . Other sources of contamination include reagents (such as K 2 CO 3 , solvents, etc.) 38 , and anion exchange cartridges (e.g., quaternary methylammonium, QMA) that are often used in the first step of 18 F-radiosyntheses 39 .
We hypothesize that 19 F-contamination could be significantly decreased (and A m increased) by replacing conventional radiochemistry approaches with microfluidic chips, due to orders of magnitude reduction in volumes and surface areas. Recently, droplet-based radiochemistry systems operating at the microliter scale have been developed 40, 41 . Despite the small volumes, these chips can produce clinically relevant amounts of PET tracers by pre-concentrating the radioisotope 42 . A few preliminary results have suggested that A m of tracers produced with this platform may be significantly higher than macroscale methods 40, [43] [44] [45] [46] . Here, we report on a comprehensive study of these differences in A m , comparing radiosyntheses of two model compounds performed at the micro-and macroscales. We observed interesting trends that shed light on the relative magnitude of the various contributions of 19 F-contamination. Microscale radiochemistry, it turns out, provides intrinsic advantages compared to conventional methods and could provide a means for consistently achieving high A m without requiring the high starting activities that are necessary in macroscale processes.
Results
Factors affecting molar activity. Micro-and macroscale radiosynthesis were compared using two model precursors: 1,4-dinitrobenzene for aromatic fluorination leading to 1-[ 18 (Fig. 1) . The microscale synthesis was performed on a microdroplet synthesis platform (Fig. 2) , and the macroscale synthesis, with a commercial synthesizer (ELIXYS, Sofie Biosciences, Inc.). The experimental design is illustrated in Fig. 3 F]fluoride drying process, and the amount of precursor was varied in proportion by adding different volumes of the stock solution. Indeed, macroscale syntheses performed with increasing reaction volumes from 0.1 to 3.0 mL showed decreasing molar activity (Fig. 4a) . For example, for [ 18 F]FNB, A m resulting from 0.1 mL reaction volume was nearly 10× higher than for the 3.0 mL reaction, i.e., 0.41 ± 0.04 Ci/µmol [15.2 ± 1.5 GBq/µmol] (n = 3) vs. 0.04 ± 0.03 Ci/µmol [1.5 ± 1.1 GBq/µmol] (n = 3), respectively. The same synthesis (starting with similar amount of radioactivity) in the microchip produced much higher A m , 22.7 ± 0.6 Ci/µmol [840 ± 22 GBq/µmol] (n = 12), and A m was nearly constant despite fluorination volume variation from 2 to 8 µL (Fig. 4b ). For [ 18 F] fallypride, A m was also found to be nearly constant (18.2 ± 0.4 Ci/ µmol [673 ± 15 GBq/µmol], n = 12) in microscale volumes from 2 to 8 µL (Fig. 4b) . Though variation in A m of [ 18 F]fallypride at the macroscale was not systematically measured as a function of reaction volume, we noted that A m for the synthesis at 0.5 mL scale was significantly lower (i.e., 0.9 ± 0.05 Ci/µmol [33 ± 2 GBq/ µmol]; n = 3) than the chip results. These data demonstrate that reagents are the dominant source of 19 F-contamination at the macroscale, but are negligible relative to other sources at the microscale.
Though not related to molar activity, it is interesting to note that the decay-corrected radiochemical conversion of [ 18 F] fluoride into 18 F-labeled tracer in macro-and microscales (as measured by radio-TLC) were similar, and remained relatively constant across all volumes tested. Conversion was 67 ± 9% (n = 11) at the macroscale and 54 ± 14% (n = 12) at the microscale for [ 18 F]FNB, and 77 ± 1% (n = 3) and 71 ± 2% (n = 12), respectively, for [ 18 F]fallypride. Despite varying reaction volume at each synthesis scale, the conversion exhibited relatively little variation, perhaps due to the use of identical reagent concentrations.
Effect of starting radioactivity. Increasing the amount of the radioisotope is known to increase the molar activity at the macroscale, which is the rationale for using high starting radioactivities when producing a tracer with high A m 29, 30 . We compared the molar activity for both [ 18 (Fig. 4c ).
An interpretation for these results is depicted in Fig. 5 Effect of fluorinated materials. Radiolysis of fluorinated materials, such as Teflon, are known to lead to reduction in molar activity at the macroscale 37 . We investigated the possibility that the Teflon coating of the EWOD chips, in contact with reagents before and during the fluorination process, could adversely impact A m in the microscale synthesis. Surprisingly, experiments assessing the impact of Teflon exposure to the initial The above trends suggest that, in microfluidic 18 F-radiosynthesis, reagents and Teflon contact do not have an appreciable effect on A m compared to cyclotron sources of 19 Fcontamination. Microdroplet-based radiosynthesis therefore provides a route, under the radiochemist's control, for maximizing molar activity of PET tracers from a given batch of the radioisotope.
Effect of molar activity on in vivo imaging. While a few reports have compared the impact of low vs high molar activity in small animal imaging 20, [47] [48] [49] , this subject does not appear to have been extensively studied. In general, higher molar activity is expected to be important for imaging low density targets by reducing competition for binding sites with the non-radioactive form of the tracer. On the other hand, some tracers will benefit from lower A m such as those with a substantial "sink" outside of the target tissue (e.g., non-specific binding or metabolism) 27 . In general, many factors could affect imaging and optimal molar For the lowest A m in each study, the initial rapid uptake was not observed (did not occur or was shorter than the frame duration). In the cerebellum, an initially high signal rapidly decreased (Supplementary Figures 2b, 3b) , the decrease being faster for lower A m . The striatum:cerebellum ratio increased over time and was generally higher for higher molar activity, though midrange A m values (0.49-2.0 Ci/µmol [18-74 GBq/µmol]) seemed to provide the greatest ratio ( Supplementary  Figures 2c, 3c) . While additional studies involving more replicates and increased coverage of A m values are needed to develop a better understanding of the influence of A m , it is clear from these results that, at least for [ 18 F]fallypride, molar activity can have substantial impact on the quantitative analysis and qualitative interpretation of PET images.
Discussion
Our study showed that macroscale and microscale radiosynthesis had marked differences in the effect of several parameters on molar activity of 18 F-labeled PET tracers. The data suggest that the advantage of microscale synthesis is the minimization of 19 It should be appreciated that, in the microscale experiments presented here, high molar activity was achieved even using only very low starting radioactivity (e.g., 1 mCi [37 MBq]). Normally, the production of tracers with such high A m requires starting with multiple Ci [e.g., 100-200 GBq] of radioactivity. The ability to work with orders of magnitude less radioactivity and still achieve high A m has the important benefits of (i) greater safety, (ii) lower requirement for radiation shielding (e.g., enabling production to be performed with an L-block instead of a mini-cell or hot-cell), (iii) reduced radiation exposure during manual manipulations if needed, (iv) reduced radiation damage to equipment, tubing, etc., and (v) reduced radioisotope cost. Furthermore, if the tracer is intended for preclinical imaging, where especially high A m may be critical 19 , microscale synthesis makes it possible to produce only what is needed, as it is needed, rather than the conventional macroscale approach of a single high-radioactivity tracer production for the purpose of boosting A m with much of the batch left unused. This is also an important concept for emerging technologies for benchtop production of PET tracers 51 , where radiation shielding, and therefore total amount of radioactivity MeOH is added (m) to dilute the crude product. n The diluted product is removed from the chip. Steps m-n are repeated for the cover chip as well that can be safely handled, will be limited. In these cases, it might be impossible to produce sufficiently high A m without the use of microvolume radiochemistry. This ability to reliably synthesize tracers with high A m provides important advantages in the screening and development of novel tracers, especially at early stages when very little may be known about toxicity, pharmacokinetics, target abundance, etc. Since the impact of A m on qualitative and quantitative imaging can be significant, as was seen with [ 18 F]fallypride, it may be desirable to always err on the side of very high A m to avoid potential pharmacologic response or target occupancy issues (which could lead to false negative results). Alternatively, it may be useful to be able to produce a small batch of a new tracer with very high A m , aliquot several portions and adjust each to a different (lower) A m by addition of non-radioactive tracer, and then studying the effect in vivo to determine the optimal range of molar activity for the intended application. High A m also enables increases in throughput of animal experiments by enabling the batch of tracer to be used over a longer period of time and still have sufficient molar activity at the time of injection.
We suspect the ability of microscale radiosynthesis to achieve high molar activity is not limited to the model compounds chosen here, and can likely be generalized to most 18 F-labeled tracers 44 and potentially also to tracers labeled with other isotopes (e.g., radiometals). In addition to reducing isotopic contamination, microvolume radiochemistry may also provide a simple route to reduce the absolute amount of precursor used, while maintaining a high concentration of reagent during the radiolabeling reaction to ensure a fast reaction rate. This will improve A m for isotopic exchange reactions 33 and apparent A m for labeling of larger molecules such as proteins, where labeled and unlabeled species cannot be separated during purification. Furthermore, reduction in precursor would likely enable simpler purification processes.
In summary, we showed that shrinking the volume scale of typical radiochemistry equipment from~1 mL to the 1-10 µL range enabled the production of PET radiotracers with consistently high molar activity (~20 Ci/µmol [740 GBq/µmol]), independent of parameters such as the reaction volume and amount of starting radioactivity. Furthermore, these high A m values could be obtained starting with very low amounts of O]water solution was obtained in a volume of~1.0 mL. The delivery time from the production site to our facility was sufficient to ensure any nitrogen-13 produced in the bombardment had decayed by the time of use.
Analytical methods. Radioactivity was determined using a calibrated ion chamber (CRC-25 PET, Capintec).
Fluorination efficiency (conversion efficiency) was analyzed via radio thin layer chromatography (radio-TLC). A sample was spotted onto a TLC plate (IB-F silica gel plates, BakerFlex). After developing in the mobile phase, the plate was dried and scanned by a radio-TLC scanner (MiniGITA star, Raytest USA, Inc, Wilmington, NC Analytical HPLC analysis for determination of purity and molar activity was performed on a Smartline HPLC system (Knauer, Germany), equipped with a degasser (Model 5050), pump (Model 1000), Phenomenex Luna reversed-phase C-18 column (250 × 4.6 mm) equipped with guard column (SecurityGuard C-18, Phenomenex, Torrance, CA), a variable wavelength UV detector (Model 2500) and a radiometric detector (Bioscan B-FC-4000, Bioscan Inc., Washington DC, USA). Determination of molar activity. A 20-µL portion of the unknown sample was aspirated in a 50-µL glass syringe (Hamilton) and the radioactivity was measured via dose calibrator. The sample was injected into HPLC, and the radioactivity of the empty syringe was measured. The decay-corrected difference in measurements represents the actual amount of radioactivity injected into HPLC. For samples comprising crude reaction products, this amount of radioactivity also includes any impurities that may be present in the crude mixture (e.g., unreacted [ 18 F]fluoride and other 18 F-labeled species); therefore, the radioactivity amount was further corrected by multiplying by the radiochemical purity (RCP) of the desired species. Because of known losses of [ 18 F]fluoride in HPLC columns 52 , the radiochemical purity was determined via a two-step process. (i) Radio-TLC analysis of the sample yielded a chromatogram with two peaks: one (R f = 0.0) representing unreacted [ 18 F]fluoride, and the other (R f =~0.75 for fallypride, R f =~0.8 for FNB) representing the radiofluorinated product (plus other potential fluorinated impurities). The area of the second peak divided by area of both peaks represents the fraction of non-fluoride species. (ii) From the radio-HPLC analysis, a chromatogram is obtained from the radiation detector, showing separation of the various nonfluoride radioactive species. The fraction of desired product is calculated by dividing the area under the peak matching the desired non-radioactive standard by the sum of areas of all other peaks (ignoring the underestimated fluoride peak). The RCP is the product of these two fractions. The injected radioactivity is then multiplied by the RCP to estimate the amount of the desired product ([ 18 F]fallypride or [ 18 F]FNB) that was actually injected into the radio-HPLC.
From the UV detector chromatogram, the area under the curve (AUC) of the peak corresponding to the tracer is determined. Using the appropriate calibration curve, this value is converted to the number of moles of compound injected. Finally, the determined radioactivity value was divided by molar amount of the tracer to obtain the molar activity.
To avoid introducing A m variations caused by different times of use of the radioactivity, which would confound the phenomena we were trying to study, all A m values were decay-corrected to the end of bombardment (EOB). For imaging purposes, we recognize that one would generally be interested in the molar activity at the time of injection. Assuming the synthesis is started at EOB (to maximize A m and the available amount of radioactivity), then A m at the time of injection would typically be 43% lower than the decay-corrected values we report (estimating synthesis and formulation time of~90 min). To build the calibration curves (Supplementary Figure 4) , stock solutions of fallypride and FNB reference standards were injected into HPLC, resulting in chromatograms with a single peak. The amount injected was varied by using different injection volumes. The AUC of each peak was determined, and the AUCs were plotted as a function of injected amount of each compound. A linear least squares fit was then performed for each compound (R 2 = 0.9906 for fallypride and R 2 = 0.9986 for FNB). The range of concentrations was chosen to cover the expected range of masses in samples.
Theoretically, chlorination of the precursor is also possible by chloride ions that may be present as contamination in the initial [ 18 F]fluoride solution originating from the cyclotron or might be present in reagents. To ensure that UV peaks represent only the fluorinated form, we compared the retention times of the standard solutions of the fluoro-and chloro-derivatives (Supplementary Figure 5) . These forms will well-separated, ruling out the possibility that the chloroderivatives could affect the molar activity measurements.
Microscale radiosynthesis platform. Microscale radiosynthesis was carried out in droplets on model EWOD chips consisting of Teflon AF-coated glass slides (Fig. 2) . These simplified chips are significantly less expensive than EWOD chips, but have similar thermal properties and identical materials in contact with the reaction mixture. Fabrication of chips was similar to previously reported methods 40 . The chips were made from glass pieces (25 mm × 25 mm) cut from standard microscope slides (Fisherbrand Plain Glass Microscope Slides). After cleaning with MeOH, acetone, and DI water, the glass pieces were spin-coated with a 1% Teflon ® AF2400 solution (prepared by diluting the 6% solution with Fluorinert ® FC40). The coating protocol consisted of three steps: 5 s at 500 rpm (100 rpm/s ramping rate), 30 s at 1000 rpm (100 rpm/s ramping rate), and then 0 rpm (500 rpm/s ramping rate). Subsequently, Teflon-coated glass slides were placed in an open Pyrex ® Petri dish, and underwent baking on a hotplate at 150, 180, and 350°C for 10, 10, and 60 min, respectively, to remove solvent and anneal the Teflon layer.
To control temperature, the chip was affixed on top of a small aluminum heating block (1 × 1 × 1 cm) containing a thermistor for temperature measurement. The heating block was in turn was placed on top of a thermoelectric (Peltier) heating/cooling element. Temperature was maintained using a thermoelectric controller (5R7-001, McShane Inc., Medina, OH, USA). Thermal paste (OmegaTherm 201, Omega Engineering, Inc., Norwalk, CT, USA) was applied between components to ensure good thermal contact. Reagents were loaded onto the chip via micropipette. (8 µL) and evaporating at 105°C for 1 min. Note that the dried residue covers an area much smaller than the original droplet size. A droplet of precursor solution (4 µL) was added to the residue site, and the reaction droplet was then sandwiched by placing a separate Teflon-glass plate as a "cover plate" on top of the droplet. The gap height was set to~150 µm by using small pieces of double-sided Scotch 3 M tape spacers attached to the edges of the second glass plate. The fluorination reaction was performed by heating to 105°C for 7 min. To collect the crude product for analysis, the top chip was removed and a droplet of MeOH (20 µL) was added to each chip, briefly mixed, and collected with a pipette. This process was repeated an additional time, resulting in a total collected volume of~80 µL.
When used for imaging, the crude [ 18 F]fallypride was purified using the analytical-scale HPLC method described above, except with flow rate of 1 mL/min (giving retention time of~12 min). The collected eluate was subsequently evaporated in a V-vial using an oil bath (110°C), redissolved in a 3% v/v EtOH: saline mixture (1 mL) and passed through 0.22 µm sterilizing filter (Anotop ® 10 Plus, Whatman) into a sterile empty vial. The final activity in the product vial was 10 mCi [0. 6 mL) , and subsequently dried at 110°C until almost dry (2.5 min). Anhydrous MeCN (1 mL) was then added to reaction vial to azeotropically remove water from the solution by heating at 110°C until complete dryness (1.5 min). This step was repeated an additional time to ensure sufficient removal of water. Next, precursor solution (0.5 mL) was added into reactor vial containing the dried [ 18 F]TBAF complex. The fluorination reaction was performed at 110°C for 7 min, and the resulting crude mixture was analyzed. In addition, all the chips used throughout the whole day were taken from the same fabrication batch, and reagents and solvents used were taken from the same product batch.
Note that processing of [ 18 F]fluoride via an anion exchange cartridge (e.g., quaternary methylammonium, QMA) was not performed in these studies, as the 19 F-contamination introduced in typical preconditioning processes 39 could confound the measurements. Detailed investigation of this step and optimization for high A m will be performed in the future. Table 2 ). Different volumes of base/phase transfer catalyst stock solutions were added to each vial during [ 18 F]fluoride dyring, and corresponding volumes of precursor stock solution were added to each vial during the fluorination reaction. Reactions were performed in a back-to-back fashion in the ELIXYS radiosynthesizer using multiple reactor positions, and multiple reagent delivery positions for each reactor. A m was compared for the different reactions. The set of four reactions was repeated three times (on different days). The microscale syntheses were performed in an analogous fashion (Fig. 3c) , and the syntheses was carried out at described above. A m of the crude reaction mixtures from different chips were compared. The set of four reactions was repeated three times (on different days) for each of the model compounds.
Effect of starting radioactivity on molar activity. The effect of starting radioactivity on A m was explored at both the macroscale and microscale for both model compounds. For the macroscale case (Fig. 3b) F]FNB synthesis was carried out as described above except all reagent volumes were reduced 2× (i.e., to match 500 µL fluorination volume). For the microscale experiments (Fig. 3d) , synthesis of the two compounds was performed as described above (i.e., with 4 µL fluorination reaction volume), except varied volumes of additional [ 18 F]fluoride/[ 18 O]H 2 O were added after the 8 µL of [ 18 F]fluoride/base solution to achieve different starting radioactivities. Note that when the total volume was >200 µL, the capacity of the chip was exceeded, and it was necessary to load a portion at a time (up to 200 µL) and dry it, before adding the next portion.
Effects of Teflon surface on molar activity. Since it is known that radiolysis of bulk Teflon can introduce [ 19 F]fluoride ion into the reaction mixture in proportion to the time of exposure, surface area of exposure, and amount of radioactivity 37 , we also performed several experiments to evaluate if there is any influence of the Teflon coating on molar activity of a probe synthesized using the microchip (see Supplementary Methods).
In vivo imaging and analysis. Beginning with a high A m production of [ 18 F]fallypride using a microfluidic chip, four formulations with different A m (at time of injection) were prepared by relying both on radioactive decay and spiking with non-radioactive standard ([ 19 F]Fallypride). A m of each formulation was separately measured via analytical radio-HPLC just prior to injection. Static and dynamic imaging was performed to determine the effects of A m on imaging.
All in vivo imaging studies were conducted in accordance with UCLA Animal Research Committee-approved protocols and guidelines. Healthy female BALB/c mice (8 weeks old) were anesthetized with 2% isoflurane in oxygen, catheterized via tail vein, and injected with~100 µCi [~3.7 MBq] [ 18 F]fallypride via catheter. Mice underwent either 10-min static PET scans after a 60 min uptake period under anesthesia or 70-min dynamic PET scans (Inveon microPET, Siemens Medical Solutions USA Inc.). Images were processed with 3D histogramming and reconstruction with a zoom factor of 2.1 using 3D-OSEM with two iterations followed by MAP with 18 iterations. All PET procedures were followed with CT scans (CrumpCAT microCT 56 ) for anatomical co-registration. PET/CT images were analyzed using AMIDE version 1.0.5 57 . Regions of interest (ROIs) were drawn for the left striatum, right striatum, and cerebellum to calculate the ratio of specific (striatal) to non-specific (cerebellum) [ 18 F]fallypride binding.
Data availability. All data generated or analyzed during this study are included in this published article (and its supplementary information files).
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